Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on July 31, 2025

Naples Laser & Skin Aesthetics Helps Upgrade Your Look With Professional Lip Fillers
Naples Laser …

MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant
Massive Bio launches Patient Connect …

Introducing Point-of-Care Media: A Point-of-Care Partners Subsidiary Focused on Messaging at the Moment Care Happens
HOLLYWOOD, FL, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Point-of-Care Partners (POCP) is excited to announce the launch of Point-of-Care Media. This new subsidiary will help pharmaceutical manufacturers optimize messaging services within …

South Florida Clinic Highlights Root-Cause Medicine as Answer to Growing Chronic Health Epidemic
Transformity Health launches expanded functional medicine programs to help patients address the underlying drivers of disease. FL, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- With chronic health conditions affecting millions of Americans each …

Florida Clinic Embeds Root‑Cause Functional Medicine Within Rising U.S. Chronic Disease Crisis
Transformity Health embraces science‑based, holistic care in response to rising chronic illness and increased reliance on complementary medicine nationwide. FL, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- As chronic diseases continue to escalate …

Naples Laser & Skin Aesthetics Now Offers Medical-Grade Peels for Advanced Skin Renewal
Naples Laser …

Press release: Online availability of Sanofi’s half-year financial report for 2025
Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed with the French market regulator Autorite …

Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sanofi
Mise en ligne du rapport financier semestriel 2025 de Sanofi Paris, le 31 juillet 2025. Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son rapport financier semestriel au 30 juin …

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …

Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia
Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a significant risk of complications that …

A Power Move Among Longevity Leaders: Global Longevity Summit and A4M Join Forces, Spearhead Definitive Event on the Life Extension Frontier
GENEVA, SWITZERLAND, July 31, 2025 (GLOBE NEWSWIRE) -- In a landmark strategic alliance, the Global Longevity Summit and the American Academy of Anti-Aging Medicine (A4M) have joined forces to launch a singular forum dedicated to harnessing the radical …

Accelerating Alzheimer’s Research: Groundbreaking Alzheimer's Disease Dataset Now Available to the Public
WASHINGTON, July 31, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) announced today that data generated from the Bio-Hermes-001 study are now publicly available. …

Silexion Therapeutics Announces New Preclinical Data Showing Up to 97% Inhibition of Cancer Cell Growth, Including New Evidence Against New Previously Untested KRAS Mutation
Grand Cayman, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced …

ADR Ratio Change Effective
July 31, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Effective ADSs Outstanding Post Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative …

Global Kombucha Market Set to Reach $5.9 Billion by 2029, Driven by Health and Wellness Trends
Delray Beach, FL, July 31, 2025 (GLOBE NEWSWIRE) -- The global kombucha market is undergoing a significant transformation, propelled by rising consumer awareness and the increasing shift toward healthier beverage alternatives. According to a recent report …

CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer
HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- CoRegen, a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the appointment of industry veteran Sonal Gupta, M.D., Ph.D., as …

Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® Technology
MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have been performed using the EnVisio® In-Body Spatial Intelligence™ platform. This milestone reflects Elucent’s ongoing …

AIM ImmunoTech Announces Closing of $8.0 Million Public Offering
OCALA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the closing of its previously announced public offering of an aggregate of 2,000,000 shares of its common stock (or pre-funded warrants …

GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no …

The Global Biologics Outsourcing Market Accounted for $20.7B in 2024 Driven by Rising Demand for Modality-Specific, End-to-End CDMO Capabilities, Finds Alira Health
FRAMINGHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consultancy, today released its 2025 Biologics Contract Manufacturing Report, a comprehensive resource tracking the evolution of the global contract development and …